nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—germ cell cancer	0.206	0.298	CbGbCtD
Zaleplon—CYP3A7—Ifosfamide—germ cell cancer	0.131	0.19	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.131	0.19	CbGbCtD
Zaleplon—CYP3A5—Ifosfamide—germ cell cancer	0.0986	0.143	CbGbCtD
Zaleplon—CYP3A5—Etoposide—germ cell cancer	0.0471	0.0681	CbGbCtD
Zaleplon—CYP3A4—Ifosfamide—germ cell cancer	0.0384	0.0556	CbGbCtD
Zaleplon—CYP3A4—Vinblastine—germ cell cancer	0.0204	0.0295	CbGbCtD
Zaleplon—CYP3A4—Etoposide—germ cell cancer	0.0184	0.0266	CbGbCtD
Zaleplon—TSPO—appendage—germ cell cancer	0.00419	0.0457	CbGeAlD
Zaleplon—GABRA2—ganglion—germ cell cancer	0.00317	0.0346	CbGeAlD
Zaleplon—TSPO—blood vessel—germ cell cancer	0.00233	0.0254	CbGeAlD
Zaleplon—CYP3A4—urine—germ cell cancer	0.002	0.0218	CbGeAlD
Zaleplon—GABRG2—trigeminal ganglion—germ cell cancer	0.0017	0.0186	CbGeAlD
Zaleplon—AOX1—trigeminal ganglion—germ cell cancer	0.00169	0.0184	CbGeAlD
Zaleplon—TSPO—neck—germ cell cancer	0.00167	0.0182	CbGeAlD
Zaleplon—GABRB2—brainstem—germ cell cancer	0.00151	0.0164	CbGeAlD
Zaleplon—AOX1—eye—germ cell cancer	0.00145	0.0158	CbGeAlD
Zaleplon—TSPO—trigeminal ganglion—germ cell cancer	0.00144	0.0157	CbGeAlD
Zaleplon—TSPO—embryo—germ cell cancer	0.00139	0.0152	CbGeAlD
Zaleplon—GABRA2—brainstem—germ cell cancer	0.00138	0.015	CbGeAlD
Zaleplon—GABRB2—telencephalon—germ cell cancer	0.00134	0.0146	CbGeAlD
Zaleplon—GABRG2—telencephalon—germ cell cancer	0.00134	0.0146	CbGeAlD
Zaleplon—GABRA1—brainstem—germ cell cancer	0.00133	0.0145	CbGeAlD
Zaleplon—GABRB3—trigeminal ganglion—germ cell cancer	0.00131	0.0143	CbGeAlD
Zaleplon—TSPO—brainstem—germ cell cancer	0.00128	0.0139	CbGeAlD
Zaleplon—CYP3A7—endocrine gland—germ cell cancer	0.00126	0.0137	CbGeAlD
Zaleplon—AOX1—decidua—germ cell cancer	0.00126	0.0137	CbGeAlD
Zaleplon—TSPO—eye—germ cell cancer	0.00124	0.0135	CbGeAlD
Zaleplon—TSPO—retina—germ cell cancer	0.00123	0.0134	CbGeAlD
Zaleplon—GABRA2—telencephalon—germ cell cancer	0.00122	0.0133	CbGeAlD
Zaleplon—GABRA1—telencephalon—germ cell cancer	0.00118	0.0129	CbGeAlD
Zaleplon—TSPO—telencephalon—germ cell cancer	0.00113	0.0123	CbGeAlD
Zaleplon—GABRB3—eye—germ cell cancer	0.00113	0.0123	CbGeAlD
Zaleplon—AOX1—gonad—germ cell cancer	0.00111	0.0121	CbGeAlD
Zaleplon—AOX1—uterus—germ cell cancer	0.0011	0.012	CbGeAlD
Zaleplon—GABRG2—pituitary gland—germ cell cancer	0.00109	0.0119	CbGeAlD
Zaleplon—TSPO—skin of body—germ cell cancer	0.00108	0.0118	CbGeAlD
Zaleplon—AOX1—pituitary gland—germ cell cancer	0.00108	0.0118	CbGeAlD
Zaleplon—TSPO—decidua—germ cell cancer	0.00107	0.0117	CbGeAlD
Zaleplon—GABRG2—medulla oblongata—germ cell cancer	0.00105	0.0115	CbGeAlD
Zaleplon—GABRB2—medulla oblongata—germ cell cancer	0.00105	0.0115	CbGeAlD
Zaleplon—GABRB3—telencephalon—germ cell cancer	0.00103	0.0112	CbGeAlD
Zaleplon—AOX1—adrenal gland—germ cell cancer	0.000964	0.0105	CbGeAlD
Zaleplon—GABRG2—midbrain—germ cell cancer	0.000961	0.0105	CbGeAlD
Zaleplon—GABRB2—midbrain—germ cell cancer	0.000961	0.0105	CbGeAlD
Zaleplon—TSPO—gonad—germ cell cancer	0.000945	0.0103	CbGeAlD
Zaleplon—TSPO—uterus—germ cell cancer	0.000939	0.0102	CbGeAlD
Zaleplon—GABRG2—spinal cord—germ cell cancer	0.000938	0.0102	CbGeAlD
Zaleplon—GABRB2—spinal cord—germ cell cancer	0.000938	0.0102	CbGeAlD
Zaleplon—GABRA1—medulla oblongata—germ cell cancer	0.000929	0.0101	CbGeAlD
Zaleplon—TSPO—pituitary gland—germ cell cancer	0.000922	0.01	CbGeAlD
Zaleplon—AOX1—female gonad—germ cell cancer	0.000899	0.0098	CbGeAlD
Zaleplon—GABRA2—adrenal gland—germ cell cancer	0.00089	0.0097	CbGeAlD
Zaleplon—TSPO—medulla oblongata—germ cell cancer	0.00089	0.0097	CbGeAlD
Zaleplon—GABRB3—gonad—germ cell cancer	0.000858	0.00935	CbGeAlD
Zaleplon—GABRA1—midbrain—germ cell cancer	0.000849	0.00925	CbGeAlD
Zaleplon—GABRB3—pituitary gland—germ cell cancer	0.000837	0.00912	CbGeAlD
Zaleplon—AOX1—endocrine gland—germ cell cancer	0.000836	0.00911	CbGeAlD
Zaleplon—GABRG2—head—germ cell cancer	0.000834	0.00909	CbGeAlD
Zaleplon—GABRB2—head—germ cell cancer	0.000834	0.00909	CbGeAlD
Zaleplon—GABRA1—spinal cord—germ cell cancer	0.000828	0.00903	CbGeAlD
Zaleplon—TSPO—adrenal gland—germ cell cancer	0.000824	0.00898	CbGeAlD
Zaleplon—TSPO—midbrain—germ cell cancer	0.000813	0.00886	CbGeAlD
Zaleplon—GABRB3—medulla oblongata—germ cell cancer	0.000808	0.0088	CbGeAlD
Zaleplon—GABRB2—testis—germ cell cancer	0.000805	0.00878	CbGeAlD
Zaleplon—AOX1—testis—germ cell cancer	0.000797	0.00869	CbGeAlD
Zaleplon—TSPO—bone marrow—germ cell cancer	0.000797	0.00868	CbGeAlD
Zaleplon—TSPO—spinal cord—germ cell cancer	0.000793	0.00865	CbGeAlD
Zaleplon—TSPO—female gonad—germ cell cancer	0.000768	0.00837	CbGeAlD
Zaleplon—GABRA2—head—germ cell cancer	0.000762	0.0083	CbGeAlD
Zaleplon—GABRB2—cerebellum—germ cell cancer	0.000744	0.00811	CbGeAlD
Zaleplon—GABRG2—cerebellum—germ cell cancer	0.000744	0.00811	CbGeAlD
Zaleplon—GABRB3—midbrain—germ cell cancer	0.000738	0.00805	CbGeAlD
Zaleplon—AOX1—cerebellum—germ cell cancer	0.000736	0.00803	CbGeAlD
Zaleplon—GABRA1—head—germ cell cancer	0.000736	0.00802	CbGeAlD
Zaleplon—GABRB3—spinal cord—germ cell cancer	0.00072	0.00785	CbGeAlD
Zaleplon—TSPO—endocrine gland—germ cell cancer	0.000714	0.00778	CbGeAlD
Zaleplon—TSPO—head—germ cell cancer	0.000705	0.00769	CbGeAlD
Zaleplon—TSPO—testis—germ cell cancer	0.000681	0.00742	CbGeAlD
Zaleplon—GABRA2—cerebellum—germ cell cancer	0.000679	0.00741	CbGeAlD
Zaleplon—GABRA1—cerebellum—germ cell cancer	0.000657	0.00716	CbGeAlD
Zaleplon—GABRB3—endocrine gland—germ cell cancer	0.000648	0.00707	CbGeAlD
Zaleplon—GABRB3—head—germ cell cancer	0.00064	0.00698	CbGeAlD
Zaleplon—TSPO—cerebellum—germ cell cancer	0.000629	0.00686	CbGeAlD
Zaleplon—GABRB3—testis—germ cell cancer	0.000618	0.00674	CbGeAlD
Zaleplon—GABRG2—brain—germ cell cancer	0.000604	0.00658	CbGeAlD
Zaleplon—GABRB2—brain—germ cell cancer	0.000604	0.00658	CbGeAlD
Zaleplon—AOX1—brain—germ cell cancer	0.000598	0.00652	CbGeAlD
Zaleplon—AOX1—lymph node—germ cell cancer	0.000578	0.0063	CbGeAlD
Zaleplon—GABRB3—cerebellum—germ cell cancer	0.000571	0.00623	CbGeAlD
Zaleplon—GABRA2—brain—germ cell cancer	0.000552	0.00602	CbGeAlD
Zaleplon—GABRA1—brain—germ cell cancer	0.000533	0.00581	CbGeAlD
Zaleplon—GABRA2—lymph node—germ cell cancer	0.000533	0.00581	CbGeAlD
Zaleplon—TSPO—brain—germ cell cancer	0.000511	0.00557	CbGeAlD
Zaleplon—Immune system disorder—Ifosfamide—germ cell cancer	0.000501	0.00232	CcSEcCtD
Zaleplon—Chills—Ifosfamide—germ cell cancer	0.000498	0.0023	CcSEcCtD
Zaleplon—Vaginal infection—Methotrexate—germ cell cancer	0.000494	0.00228	CcSEcCtD
Zaleplon—TSPO—lymph node—germ cell cancer	0.000494	0.00538	CbGeAlD
Zaleplon—Pneumonia—Etoposide—germ cell cancer	0.000491	0.00227	CcSEcCtD
Zaleplon—Paraesthesia—Vinblastine—germ cell cancer	0.000491	0.00227	CcSEcCtD
Zaleplon—Alopecia—Ifosfamide—germ cell cancer	0.000491	0.00226	CcSEcCtD
Zaleplon—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000489	0.00226	CcSEcCtD
Zaleplon—Anaemia—Dactinomycin—germ cell cancer	0.000487	0.00225	CcSEcCtD
Zaleplon—Mental disorder—Ifosfamide—germ cell cancer	0.000486	0.00225	CcSEcCtD
Zaleplon—Malnutrition—Ifosfamide—germ cell cancer	0.000483	0.00223	CcSEcCtD
Zaleplon—Myalgia—Bleomycin—germ cell cancer	0.000481	0.00222	CcSEcCtD
Zaleplon—Chest pain—Bleomycin—germ cell cancer	0.000481	0.00222	CcSEcCtD
Zaleplon—Neuropathy peripheral—Etoposide—germ cell cancer	0.000479	0.00221	CcSEcCtD
Zaleplon—Stomatitis—Etoposide—germ cell cancer	0.000476	0.0022	CcSEcCtD
Zaleplon—Discomfort—Bleomycin—germ cell cancer	0.000476	0.0022	CcSEcCtD
Zaleplon—CYP3A5—female gonad—germ cell cancer	0.000476	0.00518	CbGeAlD
Zaleplon—Malaise—Dactinomycin—germ cell cancer	0.000476	0.0022	CcSEcCtD
Zaleplon—Decreased appetite—Vinblastine—germ cell cancer	0.000475	0.00219	CcSEcCtD
Zaleplon—Bladder pain—Methotrexate—germ cell cancer	0.000473	0.00218	CcSEcCtD
Zaleplon—Mouth ulceration—Methotrexate—germ cell cancer	0.000473	0.00218	CcSEcCtD
Zaleplon—Ecchymosis—Methotrexate—germ cell cancer	0.000473	0.00218	CcSEcCtD
Zaleplon—Pain—Vinblastine—germ cell cancer	0.000467	0.00216	CcSEcCtD
Zaleplon—Constipation—Vinblastine—germ cell cancer	0.000467	0.00216	CcSEcCtD
Zaleplon—Confusional state—Bleomycin—germ cell cancer	0.000465	0.00215	CcSEcCtD
Zaleplon—GABRB3—brain—germ cell cancer	0.000464	0.00506	CbGeAlD
Zaleplon—Hepatobiliary disease—Etoposide—germ cell cancer	0.000462	0.00213	CcSEcCtD
Zaleplon—Oedema—Bleomycin—germ cell cancer	0.000461	0.00213	CcSEcCtD
Zaleplon—Anaphylactic shock—Bleomycin—germ cell cancer	0.000461	0.00213	CcSEcCtD
Zaleplon—Visual impairment—Cisplatin—germ cell cancer	0.000461	0.00213	CcSEcCtD
Zaleplon—Feeling abnormal—Vinblastine—germ cell cancer	0.00045	0.00208	CcSEcCtD
Zaleplon—Myalgia—Dactinomycin—germ cell cancer	0.000449	0.00207	CcSEcCtD
Zaleplon—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000448	0.00207	CcSEcCtD
Zaleplon—Eye disorder—Cisplatin—germ cell cancer	0.000447	0.00207	CcSEcCtD
Zaleplon—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000447	0.00206	CcSEcCtD
Zaleplon—Anaemia—Ifosfamide—germ cell cancer	0.000447	0.00206	CcSEcCtD
Zaleplon—Tinnitus—Cisplatin—germ cell cancer	0.000446	0.00206	CcSEcCtD
Zaleplon—Lymphadenopathy—Methotrexate—germ cell cancer	0.000445	0.00205	CcSEcCtD
Zaleplon—Agitation—Ifosfamide—germ cell cancer	0.000444	0.00205	CcSEcCtD
Zaleplon—Discomfort—Dactinomycin—germ cell cancer	0.000444	0.00205	CcSEcCtD
Zaleplon—CYP3A5—endocrine gland—germ cell cancer	0.000442	0.00482	CbGeAlD
Zaleplon—Angioedema—Ifosfamide—germ cell cancer	0.000442	0.00204	CcSEcCtD
Zaleplon—Anorexia—Bleomycin—germ cell cancer	0.00044	0.00203	CcSEcCtD
Zaleplon—Thrombophlebitis—Methotrexate—germ cell cancer	0.000439	0.00202	CcSEcCtD
Zaleplon—Diabetes mellitus—Methotrexate—germ cell cancer	0.000436	0.00202	CcSEcCtD
Zaleplon—Hypoaesthesia—Etoposide—germ cell cancer	0.000436	0.00201	CcSEcCtD
Zaleplon—Malaise—Ifosfamide—germ cell cancer	0.000436	0.00201	CcSEcCtD
Zaleplon—Vertigo—Ifosfamide—germ cell cancer	0.000434	0.002	CcSEcCtD
Zaleplon—Photosensitivity—Methotrexate—germ cell cancer	0.000432	0.002	CcSEcCtD
Zaleplon—Immune system disorder—Cisplatin—germ cell cancer	0.000432	0.002	CcSEcCtD
Zaleplon—Abdominal pain—Vinblastine—germ cell cancer	0.000432	0.00199	CcSEcCtD
Zaleplon—Hypotension—Bleomycin—germ cell cancer	0.000431	0.00199	CcSEcCtD
Zaleplon—Oedema—Dactinomycin—germ cell cancer	0.00043	0.00199	CcSEcCtD
Zaleplon—Palpitations—Ifosfamide—germ cell cancer	0.000427	0.00197	CcSEcCtD
Zaleplon—Alopecia—Cisplatin—germ cell cancer	0.000423	0.00195	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00042	0.00194	CcSEcCtD
Zaleplon—Hypertension—Ifosfamide—germ cell cancer	0.000417	0.00193	CcSEcCtD
Zaleplon—Malnutrition—Cisplatin—germ cell cancer	0.000417	0.00192	CcSEcCtD
Zaleplon—Paraesthesia—Bleomycin—germ cell cancer	0.000414	0.00191	CcSEcCtD
Zaleplon—Dyspnoea—Bleomycin—germ cell cancer	0.000411	0.0019	CcSEcCtD
Zaleplon—Arthralgia—Ifosfamide—germ cell cancer	0.000411	0.0019	CcSEcCtD
Zaleplon—Chest pain—Ifosfamide—germ cell cancer	0.000411	0.0019	CcSEcCtD
Zaleplon—Myalgia—Ifosfamide—germ cell cancer	0.000411	0.0019	CcSEcCtD
Zaleplon—Flatulence—Cisplatin—germ cell cancer	0.000411	0.0019	CcSEcCtD
Zaleplon—Anorexia—Dactinomycin—germ cell cancer	0.00041	0.00189	CcSEcCtD
Zaleplon—Eye disorder—Etoposide—germ cell cancer	0.00041	0.00189	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000409	0.00189	CcSEcCtD
Zaleplon—Discomfort—Ifosfamide—germ cell cancer	0.000407	0.00188	CcSEcCtD
Zaleplon—Decreased appetite—Bleomycin—germ cell cancer	0.000401	0.00185	CcSEcCtD
Zaleplon—Confusional state—Ifosfamide—germ cell cancer	0.000398	0.00184	CcSEcCtD
Zaleplon—Immune system disorder—Etoposide—germ cell cancer	0.000396	0.00183	CcSEcCtD
Zaleplon—Pain—Bleomycin—germ cell cancer	0.000395	0.00182	CcSEcCtD
Zaleplon—Oedema—Ifosfamide—germ cell cancer	0.000394	0.00182	CcSEcCtD
Zaleplon—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000394	0.00182	CcSEcCtD
Zaleplon—Chills—Etoposide—germ cell cancer	0.000393	0.00182	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000392	0.00181	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000392	0.00181	CcSEcCtD
Zaleplon—Asthenia—Vinblastine—germ cell cancer	0.000392	0.00181	CcSEcCtD
Zaleplon—Tremor—Cisplatin—germ cell cancer	0.00039	0.0018	CcSEcCtD
Zaleplon—Alopecia—Etoposide—germ cell cancer	0.000387	0.00179	CcSEcCtD
Zaleplon—Nervous system disorder—Ifosfamide—germ cell cancer	0.000387	0.00179	CcSEcCtD
Zaleplon—Ill-defined disorder—Cisplatin—germ cell cancer	0.000387	0.00178	CcSEcCtD
Zaleplon—Anaemia—Cisplatin—germ cell cancer	0.000385	0.00178	CcSEcCtD
Zaleplon—Skin disorder—Ifosfamide—germ cell cancer	0.000383	0.00177	CcSEcCtD
Zaleplon—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000381	0.00176	CcSEcCtD
Zaleplon—Feeling abnormal—Bleomycin—germ cell cancer	0.00038	0.00176	CcSEcCtD
Zaleplon—Osteoarthritis—Methotrexate—germ cell cancer	0.00038	0.00175	CcSEcCtD
Zaleplon—Anorexia—Ifosfamide—germ cell cancer	0.000376	0.00174	CcSEcCtD
Zaleplon—Malaise—Cisplatin—germ cell cancer	0.000376	0.00173	CcSEcCtD
Zaleplon—Decreased appetite—Dactinomycin—germ cell cancer	0.000374	0.00173	CcSEcCtD
Zaleplon—Dysgeusia—Etoposide—germ cell cancer	0.000374	0.00173	CcSEcCtD
Zaleplon—Back pain—Etoposide—germ cell cancer	0.000369	0.0017	CcSEcCtD
Zaleplon—Hypotension—Ifosfamide—germ cell cancer	0.000369	0.0017	CcSEcCtD
Zaleplon—Pain—Dactinomycin—germ cell cancer	0.000368	0.0017	CcSEcCtD
Zaleplon—Urticaria—Bleomycin—germ cell cancer	0.000367	0.00169	CcSEcCtD
Zaleplon—Body temperature increased—Bleomycin—germ cell cancer	0.000365	0.00168	CcSEcCtD
Zaleplon—Irritability—Methotrexate—germ cell cancer	0.000362	0.00167	CcSEcCtD
Zaleplon—Dizziness—Vinblastine—germ cell cancer	0.000361	0.00167	CcSEcCtD
Zaleplon—Mood swings—Methotrexate—germ cell cancer	0.00036	0.00166	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000359	0.00166	CcSEcCtD
Zaleplon—Ataxia—Methotrexate—germ cell cancer	0.000357	0.00165	CcSEcCtD
Zaleplon—Myalgia—Cisplatin—germ cell cancer	0.000355	0.00164	CcSEcCtD
Zaleplon—Feeling abnormal—Dactinomycin—germ cell cancer	0.000355	0.00164	CcSEcCtD
Zaleplon—Paraesthesia—Ifosfamide—germ cell cancer	0.000354	0.00164	CcSEcCtD
Zaleplon—Ill-defined disorder—Etoposide—germ cell cancer	0.000354	0.00164	CcSEcCtD
Zaleplon—Anxiety—Cisplatin—germ cell cancer	0.000353	0.00163	CcSEcCtD
Zaleplon—Anaemia—Etoposide—germ cell cancer	0.000353	0.00163	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000352	0.00163	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000352	0.00162	CcSEcCtD
Zaleplon—Dyspnoea—Ifosfamide—germ cell cancer	0.000352	0.00162	CcSEcCtD
Zaleplon—Somnolence—Ifosfamide—germ cell cancer	0.000351	0.00162	CcSEcCtD
Zaleplon—Liver function test abnormal—Methotrexate—germ cell cancer	0.00035	0.00162	CcSEcCtD
Zaleplon—Discomfort—Cisplatin—germ cell cancer	0.00035	0.00162	CcSEcCtD
Zaleplon—Malaise—Etoposide—germ cell cancer	0.000344	0.00159	CcSEcCtD
Zaleplon—Breast disorder—Methotrexate—germ cell cancer	0.000343	0.00158	CcSEcCtD
Zaleplon—Vertigo—Etoposide—germ cell cancer	0.000343	0.00158	CcSEcCtD
Zaleplon—Decreased appetite—Ifosfamide—germ cell cancer	0.000343	0.00158	CcSEcCtD
Zaleplon—Headache—Vinblastine—germ cell cancer	0.000342	0.00158	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000341	0.00157	CcSEcCtD
Zaleplon—Abdominal pain—Dactinomycin—germ cell cancer	0.00034	0.00157	CcSEcCtD
Zaleplon—Body temperature increased—Dactinomycin—germ cell cancer	0.00034	0.00157	CcSEcCtD
Zaleplon—Oedema—Cisplatin—germ cell cancer	0.00034	0.00157	CcSEcCtD
Zaleplon—Anaphylactic shock—Cisplatin—germ cell cancer	0.00034	0.00157	CcSEcCtD
Zaleplon—Pain—Ifosfamide—germ cell cancer	0.000337	0.00156	CcSEcCtD
Zaleplon—Constipation—Ifosfamide—germ cell cancer	0.000337	0.00156	CcSEcCtD
Zaleplon—Loss of consciousness—Etoposide—germ cell cancer	0.000335	0.00155	CcSEcCtD
Zaleplon—Nervous system disorder—Cisplatin—germ cell cancer	0.000333	0.00154	CcSEcCtD
Zaleplon—CYP3A4—endocrine gland—germ cell cancer	0.000332	0.00362	CbGeAlD
Zaleplon—Tachycardia—Cisplatin—germ cell cancer	0.000332	0.00153	CcSEcCtD
Zaleplon—Asthenia—Bleomycin—germ cell cancer	0.000331	0.00153	CcSEcCtD
Zaleplon—Skin disorder—Cisplatin—germ cell cancer	0.00033	0.00152	CcSEcCtD
Zaleplon—Hypertension—Etoposide—germ cell cancer	0.00033	0.00152	CcSEcCtD
Zaleplon—Hyperhidrosis—Cisplatin—germ cell cancer	0.000329	0.00152	CcSEcCtD
Zaleplon—Asthma—Methotrexate—germ cell cancer	0.000328	0.00151	CcSEcCtD
Zaleplon—Pruritus—Bleomycin—germ cell cancer	0.000327	0.00151	CcSEcCtD
Zaleplon—Feeling abnormal—Ifosfamide—germ cell cancer	0.000325	0.0015	CcSEcCtD
Zaleplon—Chest pain—Etoposide—germ cell cancer	0.000325	0.0015	CcSEcCtD
Zaleplon—Eosinophilia—Methotrexate—germ cell cancer	0.000325	0.0015	CcSEcCtD
Zaleplon—Nausea—Vinblastine—germ cell cancer	0.000325	0.0015	CcSEcCtD
Zaleplon—Anorexia—Cisplatin—germ cell cancer	0.000324	0.0015	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000323	0.00149	CcSEcCtD
Zaleplon—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000323	0.00149	CcSEcCtD
Zaleplon—Discomfort—Etoposide—germ cell cancer	0.000321	0.00148	CcSEcCtD
Zaleplon—Hypotension—Cisplatin—germ cell cancer	0.000318	0.00147	CcSEcCtD
Zaleplon—Confusional state—Etoposide—germ cell cancer	0.000314	0.00145	CcSEcCtD
Zaleplon—Urticaria—Ifosfamide—germ cell cancer	0.000313	0.00145	CcSEcCtD
Zaleplon—Abdominal pain—Ifosfamide—germ cell cancer	0.000312	0.00144	CcSEcCtD
Zaleplon—Body temperature increased—Ifosfamide—germ cell cancer	0.000312	0.00144	CcSEcCtD
Zaleplon—Anaphylactic shock—Etoposide—germ cell cancer	0.000312	0.00144	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00031	0.00143	CcSEcCtD
Zaleplon—Asthenia—Dactinomycin—germ cell cancer	0.000309	0.00143	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—germ cell cancer	0.000307	0.00142	CcSEcCtD
Zaleplon—Paraesthesia—Cisplatin—germ cell cancer	0.000305	0.00141	CcSEcCtD
Zaleplon—Tachycardia—Etoposide—germ cell cancer	0.000304	0.0014	CcSEcCtD
Zaleplon—Dyspnoea—Cisplatin—germ cell cancer	0.000303	0.0014	CcSEcCtD
Zaleplon—Skin disorder—Etoposide—germ cell cancer	0.000303	0.0014	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—germ cell cancer	0.000302	0.0014	CcSEcCtD
Zaleplon—Hyperhidrosis—Etoposide—germ cell cancer	0.000301	0.00139	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000299	0.00138	CcSEcCtD
Zaleplon—Anorexia—Etoposide—germ cell cancer	0.000297	0.00137	CcSEcCtD
Zaleplon—Decreased appetite—Cisplatin—germ cell cancer	0.000296	0.00136	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—germ cell cancer	0.000294	0.00136	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000294	0.00136	CcSEcCtD
Zaleplon—Depression—Methotrexate—germ cell cancer	0.000292	0.00135	CcSEcCtD
Zaleplon—Hypotension—Etoposide—germ cell cancer	0.000291	0.00134	CcSEcCtD
Zaleplon—Rash—Bleomycin—germ cell cancer	0.000291	0.00134	CcSEcCtD
Zaleplon—Pain—Cisplatin—germ cell cancer	0.000291	0.00134	CcSEcCtD
Zaleplon—Dermatitis—Bleomycin—germ cell cancer	0.000291	0.00134	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—germ cell cancer	0.000285	0.00132	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—germ cell cancer	0.000284	0.00131	CcSEcCtD
Zaleplon—Asthenia—Ifosfamide—germ cell cancer	0.000283	0.00131	CcSEcCtD
Zaleplon—Sweating—Methotrexate—germ cell cancer	0.00028	0.00129	CcSEcCtD
Zaleplon—Feeling abnormal—Cisplatin—germ cell cancer	0.00028	0.00129	CcSEcCtD
Zaleplon—Paraesthesia—Etoposide—germ cell cancer	0.00028	0.00129	CcSEcCtD
Zaleplon—Pruritus—Ifosfamide—germ cell cancer	0.000279	0.00129	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—germ cell cancer	0.000279	0.00129	CcSEcCtD
Zaleplon—Dyspnoea—Etoposide—germ cell cancer	0.000278	0.00128	CcSEcCtD
Zaleplon—Somnolence—Etoposide—germ cell cancer	0.000277	0.00128	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000277	0.00128	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—germ cell cancer	0.000276	0.00127	CcSEcCtD
Zaleplon—Nausea—Bleomycin—germ cell cancer	0.000274	0.00127	CcSEcCtD
Zaleplon—Rash—Dactinomycin—germ cell cancer	0.000271	0.00125	CcSEcCtD
Zaleplon—Decreased appetite—Etoposide—germ cell cancer	0.000271	0.00125	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000269	0.00124	CcSEcCtD
Zaleplon—Body temperature increased—Cisplatin—germ cell cancer	0.000269	0.00124	CcSEcCtD
Zaleplon—Pain—Etoposide—germ cell cancer	0.000266	0.00123	CcSEcCtD
Zaleplon—Constipation—Etoposide—germ cell cancer	0.000266	0.00123	CcSEcCtD
Zaleplon—Dizziness—Ifosfamide—germ cell cancer	0.000261	0.0012	CcSEcCtD
Zaleplon—Feeling abnormal—Etoposide—germ cell cancer	0.000257	0.00119	CcSEcCtD
Zaleplon—Nausea—Dactinomycin—germ cell cancer	0.000256	0.00118	CcSEcCtD
Zaleplon—Gastrointestinal pain—Etoposide—germ cell cancer	0.000255	0.00118	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—germ cell cancer	0.000253	0.00117	CcSEcCtD
Zaleplon—Rash—Ifosfamide—germ cell cancer	0.000249	0.00115	CcSEcCtD
Zaleplon—Dermatitis—Ifosfamide—germ cell cancer	0.000248	0.00115	CcSEcCtD
Zaleplon—Urticaria—Etoposide—germ cell cancer	0.000247	0.00114	CcSEcCtD
Zaleplon—Abdominal pain—Etoposide—germ cell cancer	0.000246	0.00114	CcSEcCtD
Zaleplon—Body temperature increased—Etoposide—germ cell cancer	0.000246	0.00114	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—germ cell cancer	0.000245	0.00113	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—germ cell cancer	0.000245	0.00113	CcSEcCtD
Zaleplon—Asthenia—Cisplatin—germ cell cancer	0.000244	0.00113	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—germ cell cancer	0.000237	0.0011	CcSEcCtD
Zaleplon—Chills—Methotrexate—germ cell cancer	0.000236	0.00109	CcSEcCtD
Zaleplon—Nausea—Ifosfamide—germ cell cancer	0.000234	0.00108	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—germ cell cancer	0.000232	0.00107	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—germ cell cancer	0.00023	0.00106	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—germ cell cancer	0.000229	0.00106	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—germ cell cancer	0.000224	0.00103	CcSEcCtD
Zaleplon—Asthenia—Etoposide—germ cell cancer	0.000224	0.00103	CcSEcCtD
Zaleplon—Back pain—Methotrexate—germ cell cancer	0.000221	0.00102	CcSEcCtD
Zaleplon—Pruritus—Etoposide—germ cell cancer	0.00022	0.00102	CcSEcCtD
Zaleplon—Rash—Cisplatin—germ cell cancer	0.000214	0.00099	CcSEcCtD
Zaleplon—Dermatitis—Cisplatin—germ cell cancer	0.000214	0.000989	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—germ cell cancer	0.000212	0.000979	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—germ cell cancer	0.000211	0.000976	CcSEcCtD
Zaleplon—Malaise—Methotrexate—germ cell cancer	0.000206	0.000952	CcSEcCtD
Zaleplon—Dizziness—Etoposide—germ cell cancer	0.000206	0.000951	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—germ cell cancer	0.000205	0.000948	CcSEcCtD
Zaleplon—Nausea—Cisplatin—germ cell cancer	0.000202	0.000933	CcSEcCtD
Zaleplon—Rash—Etoposide—germ cell cancer	0.000196	0.000907	CcSEcCtD
Zaleplon—Dermatitis—Etoposide—germ cell cancer	0.000196	0.000906	CcSEcCtD
Zaleplon—Headache—Etoposide—germ cell cancer	0.000195	0.000901	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—germ cell cancer	0.000195	0.000899	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—germ cell cancer	0.000195	0.000899	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—germ cell cancer	0.000195	0.000899	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000193	0.000892	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—germ cell cancer	0.000192	0.000888	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—germ cell cancer	0.000188	0.000869	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—germ cell cancer	0.000187	0.000861	CcSEcCtD
Zaleplon—Nausea—Etoposide—germ cell cancer	0.000185	0.000854	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—germ cell cancer	0.000183	0.000845	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—germ cell cancer	0.000181	0.000837	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—germ cell cancer	0.00018	0.000833	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—germ cell cancer	0.000178	0.000821	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—germ cell cancer	0.000174	0.000805	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00017	0.000785	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—germ cell cancer	0.000169	0.000779	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—germ cell cancer	0.000168	0.000774	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—germ cell cancer	0.000166	0.000768	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—germ cell cancer	0.000166	0.000766	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—germ cell cancer	0.000164	0.000758	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—germ cell cancer	0.000162	0.000749	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000161	0.000744	CcSEcCtD
Zaleplon—Pain—Methotrexate—germ cell cancer	0.00016	0.000737	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—germ cell cancer	0.000154	0.00071	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000153	0.000704	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—germ cell cancer	0.000148	0.000684	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—germ cell cancer	0.000148	0.000681	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—germ cell cancer	0.000148	0.000681	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—germ cell cancer	0.000134	0.000618	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—germ cell cancer	0.000132	0.00061	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—germ cell cancer	0.000123	0.00057	CcSEcCtD
Zaleplon—Rash—Methotrexate—germ cell cancer	0.000118	0.000543	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—germ cell cancer	0.000118	0.000543	CcSEcCtD
Zaleplon—Headache—Methotrexate—germ cell cancer	0.000117	0.00054	CcSEcCtD
Zaleplon—Nausea—Methotrexate—germ cell cancer	0.000111	0.000512	CcSEcCtD
